Local administration of liposomal adriamycin inhibited proliferation of metastatic cells in axillary lymph nodes in rabbit breast cancer model

Journal of Medical Colleges of PLA

Volumn 24, Issue 3, 2009, Pages 161-166

  Xiaojun, Li ^a   Hong, Qin ^a   Jia, Yao ^a   Jiansheng, Wang ^a   Yinsheng, Xian ^a   Yunfeng, Zhang ^a   Hong, Ren ^a  

^a First Affiliated Hospital   (China)

Author keywords

Breast cancer; Liposomal adriamycin; Lymphatic chemotherapy

Indexed keywords

CYCLINE; DOXORUBICIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; GENE EXPRESSION; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE;

EID: 70350077824     PISSN: 10001948     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1000-1948(09)60033-2     Document Type: Article

References (16)

1. Oussoren C., and Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 50 2 (2001) 143-156
2. Wang J.C., Hui M.Q., Jiao Y.Q., et al. Liposomal anti-tumor drugs: I. preparation of 3-vial liposomal adriamycin injection. Dig W Med J 2 4 (2003) 746-749
3. Yao Q., Chen J.H., Lin R., et al. Establishment of VX2 breast carcinoma model in rabbit by injection of tissue mass suspension. Chin J Can 14 1 (2004) 22-23 (In Chinese).
4. Mandava N., Blackburn P., Paul D.B., et al. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 43 10 (2002) 3338-3348
5. Chen J.H., Wang L., Yao Q., et al. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer. Breast Cancer Res 6 4 (2004) 474-477
6. Chen J.H., Lin R., Wang L., et al. Local administration of activated carbon-adsorbed mitomycin C in treatment of breast cancer model with metastasized axillary lymph nodes. Chin J Can Prev Treat 12 10 (2005) 729-731 (In Chinese).
7. Sagra T. Cardiac safety of liposomal anthracyclines. Oncologist 8 1 (2003) 17-24
8. Bao A., Goins B., Klipper R., et al. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non invasive imaging studies. J Pharmacol Exp Ther 308 2 (2004) 419-425
9. Mao Y., Wu J., Wang N., et al. A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer. Cancer Invest 20 7-8 (2002) 922-931
10. Takashima T., Onoda N., Ishikawa T., et al. Proliferating cell nuclear antigen labeling index and p53 expression predict outcome for breast cancer patients with four or more lymph node metastases. Int J Mol Med 8 2 (2001) 159-163
11. Ling R., Li Y., Yao Q., et al. Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model. J Drug Target 13 2 (2005) 137-142
12. Furlanut M., de Manzoni G., Pasini F., et al. Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation. Pharmacol Res 56 4 (2007) 344-349
13. Kiyokawa H., Igawa Y., Muraishi O., et al. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog. J Urol 161 2 (1999) 665-667
14. Harrington K.J., Rowlinson-Busza G., Syrigos K.N., et al. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Clin Cancer Res 6 6 (2000) 2528-2537
15. Hamaguchi S., Tohnai I., Ito A., et al. Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model. Cancer Sci 94 9 (2003) 834-839
16. Medina L.A., Klipper R., Phillips W.T., et al. Pharmacokinetics and biodistribution of [111In] avidin and [99mTc] biotin liposomes injected in the pleural space for the targeting of mediastinal nodes. Nucl Med Biol 31 1 (2004) 41-51